Table 4.
Baseline | 3 months | 12 months | P-value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Lp (a) tertiles | 3rd | 2nd | 1st | 3rd | 2nd | 1st | 3rd | 2nd | 1st | |
n = 5 | n = 5 | n = 5 | n = 5 | n = 5 | n = 4 | n = 5 | n = 5 | n = 5 | ||
Lp(a) mg/dL | 52.7 ± 13.3 | 11.8 ± 6.4 | 3.8 ± 2.0 | 53.9 ± 20.5 | 11.0 ± 5.0 | 3.2 ± 1.3 | 59.1 ± 19.6 | 13.8 ± 4.1 | 3.3 ± 0.7 | 0.023 |
Treated area MPR | 0.94 ± 0.32 | 1.16 ± 0.45 | 1.03 ± 0.34 | 1.43 ± 0.45 | 1.39 ± 0.57 | 1.17 ± 0.38 | 1.76 ± 0.41 | 1.42 ± 0.53 | 1.22 ± 0. | 0.089 |
Mean ± SD. Tertiles refer to Lp(a) at baseline. P-value for interaction time x tertiles. P-values for all comparisons in Supplementary material online, Table S2.
MPR, myocardial perfusion reserve; SD, standard deviation; Lp(a), lipoprotein(a).